IL1B and Parkinson disease: Evidence suggests that the archetypal pro-inflammatory cytokine, interleukin-1beta (IL-1β), is a key component in the pathogenesis of stroke, Alzheimer’s disease (AD) [for review, see 1] and Parkinson’s Disease (PD) [for review, see 2].